Product Description: AMG410 is a non-covalent and selective pan-KRAS inhibitor with IC50 values of 1-4 nM for KRAS G12D, KRAS G12V, and KRAS G13D. AMG410 shows greater than 100-fold selectivity against both HRAS and NRAS. AMG410 is a dual GTP(on)- and GDP(off)-state inhibitor (Kd(GDP-state) of 1 nM; Kd(GTP-state) of 22 nM). AMG410 blocks KRAS signaling in a cycling state-independent manner and also blocks proliferation in wildtype KRAS-amplified tumor cells. AMG410 can be used for the study of colorectal, pancreatic, and lung cancers[1][2].
Applications: Cancer-Kinase/protease
Formula: C31H32ClF2N7O5
References: [1]Adriano BAUER, et al. Macrocyclic kras inhibitors and methods of use. WO2024107686A1./[2]ND01 - AMG 410: An H/NRAS-sparing pan-KRAS inhibitor with dual GTP(on)/GDP(off)-state activity for the treatment of diverse KRAS-mutant tumors
CAS Number: 3040175-17-2
Molecular Weight: 656.08
Research Area: Cancer
Target: Ras
Deutsch
English
